Fecal Incontinence clinical trials at UCSF
1 research study open to eligible people
Fecal incontinence is the inability to control bowel movements. At UCSF, research is ongoing to test iltamiocel for women who experienced childbirth injuries. Scientists want to know if iltamiocel is more effective than a placebo.
Iltamiocel Compared to Placebo for Chronic Fecal Incontinence in Females With Obstetric Injury
open to eligible females ages 18 years and up
This study evaluates the efficacy and safety of a single injection of iltamiocel (300 x 10^6 cells) compared to a placebo in the reduction of fecal incontinence episode frequency in adult female participants with chronic fecal incontinence and a history of obstetric anal sphincter injury. Half of the participants will receive iltamiocel (injections with cells) and the other half will receive placebo.
San Francisco, California and other locations
Last updated: